title: Clinical relevance of occult metastatic cells in the bone marrow of patients with different stages of breast cancer.
abstract: Data are emerging about the prognostic relevance of occult metastatic cells in the bone marrow of patients with various solid tumors. Discrepancies among different studies on the prognostic relevance of isolated tumor cells may be caused by tumor cell heterogeneity and the use of different immunoassays. There is increasing evidence that validated anticytokeratin antibodies (e.g., A45-B/B3) represent the present standard for the detection of isolated tumor cells. This immunocytochemical assay allows the identification of patients with occult tumor cell dissemination that cannot be identified by conventional screening methods in tumor staging. According to recent studies, these patients are at higher risk for subsequent development of distant metastases and might therefore benefit from early systemic therapy. At advanced stages of the disease, the micrometastatic tumor load after adjuvant therapy, or at the time of emerging recurrences, appears to reflect the tumor's ability to progress. Therapeutic monitoring and cell-cycle independent antibody-based therapy are among possible implications of this new, promising diagnostic tool. The present review also focuses on state of the art, reliable detection methods of occult metastatic cells in the bone marrow of breast cancer patients and on the prognostic relevance of these cells at different stages of the disease.
authors.affiliation: I. Frauenklinik, Klinikum Innenstadt, Ludwig-Maximilians Universität, Munich, Germany. janni@fk-i.med.uni-muenchen.de
authors.forename: W
authors.initials: W
authors.lastname: Janni
authors.forename: D
authors.initials: D
authors.lastname: Rjosk
authors.forename: S
authors.initials: S
authors.lastname: Braun
mesh_terms: D000951:Antigens, Neoplasm / Q000378:metabolism; D001707:Biopsy, Needle; D019046:Bone Marrow Neoplasms / Q000378:metabolism / Q000556:secondary*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007633:Keratins / Q000378:metabolism; D009367:Neoplasm Staging; D009360:Neoplastic Cells, Circulating / Q000378:metabolism / Q000473:pathology*
chemical_list: D000951:Antigens, Neoplasm; D007633:Keratins